We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+18.4%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.28B
AUM Growth
+$253M
Cap. Flow
+$143M
Cap. Flow %
11.17%
Top 10 Hldgs %
13.47%
Holding
1,446
New
471
Increased
321
Reduced
302
Closed
327

Top Buys

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$16.8M
2
U icon
Unity
U
+$14M
3
AIFC
AI Financial Corp
AIFC
+$13.8M
4
CYBR
CyberArk
CYBR
+$12.6M
5
NSC icon
Norfolk Southern
NSC
+$11.7M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$13.2M
2
TSLA icon
Tesla
TSLA
+$12.9M
3
BIDU icon
Baidu
BIDU
+$11.9M
4
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$10M
5
AMED
Amedisys
AMED
+$8.89M

Sector Composition

Rank Sector Weight
1 Technology 21.32%
2 Communication Services 11.38%
3 Healthcare 11.08%
4 Consumer Discretionary 10.37%
5 Financials 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
A icon
826
Agilent Technologies
A
$42B
$250K 0.02%
+1,946
New +$235K
JMIA
827
Jumia Technologies
JMIA
$743M
$250K 0.02%
+21,500
New +$157K
ENVX icon
828
Enovix
ENVX
$1.01B
$249K 0.02%
25,012
+1,706
+7% +$18.9K
LEG icon
829
Leggett & Platt
LEG
$1.29B
$249K 0.02%
28,044
+16,666
+146% +$159K
BWA icon
830
BorgWarner
BWA
$14.1B
$249K 0.02%
+5,663
New +$226K
EG icon
831
Everest Group
EG
$14.2B
$249K 0.02%
+710
New +$240K
JBTM
832
JBT Marel
JBTM
$6.35B
$249K 0.02%
+1,770
New +$242K
GRND icon
833
Grindr
GRND
$2.84B
$249K 0.02%
+16,551
New +$290K
MSTY icon
834
PUT
YieldMax MSTR Option Income Strategy ETF
MSTY
$760M
$248K 0.02%
+320
New +$29.1K
LRN icon
835
Stride
LRN
$3.33B
$248K 0.02%
1,665
-581
-26% -$85.2K
ERO icon
836
Ero Copper
ERO
$3.81B
$248K 0.02%
+12,237
New +$186K
SRAD icon
837
Sportradar
SRAD
$3.95B
$247K 0.02%
9,169
-3,727
-29% -$111K
OXM icon
838
Oxford Industries
OXM
$556M
$245K 0.02%
+6,039
New +$262K
PH icon
839
Parker-Hannifin
PH
$134B
$244K 0.02%
+322
New +$238K
REVG
840
DELISTED
REV Group
REVG
$244K 0.02%
4,302
-48,235
-92% -$2.56M
COLB icon
841
Columbia Banking Systems
COLB
$8.84B
$243K 0.02%
9,429
-13,360
-59% -$339K
ARDT
842
Ardent Health
ARDT
$1.59B
$243K 0.02%
18,303
+4,259
+30% +$53.3K
CGAU
843
Centerra Gold
CGAU
$4.17B
$242K 0.02%
22,522
+6,598
+41% +$52.6K
AWI icon
844
Armstrong World Industries
AWI
$7.75B
$241K 0.02%
1,229
-434
-26% -$80.7K
MBC icon
845
MasterBrand
MBC
$1.84B
$241K 0.02%
+18,279
New +$226K
RS icon
846
Reliance Steel & Aluminium
RS
$21.9B
$240K 0.02%
+855
New +$257K
AVNS
847
DELISTED
Avanos Medical
AVNS
$240K 0.02%
20,737
-3,947
-16% -$46.2K
TJX icon
848
TJX Companies
TJX
$175B
$240K 0.02%
1,657
-2,142
-56% -$285K
EOG icon
849
EOG Resources
EOG
$74.6B
$239K 0.02%
2,136
+66
+3% +$7.87K
SLM icon
850
SLM Corp
SLM
$5.14B
$239K 0.02%
8,643
-27
-0.3% -$843
32 33
34
35 36

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Prelude Capital Management held 1,446 positions worth $1.28B, up 25% from $1.03B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Prelude Capital Management deployed $143M of net new capital in Q3 2025, opening 471 new positions and adding to 321 existing holdings. Its largest new stake was Verona Pharma: 160,565 shares worth $17.1M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $13.2M trimmed.

  • Prelude Capital Management's largest Q3 2025 buy was Verona Pharma: 160,565 shares worth $17.1M.
  • Prelude Capital Management added most to Amazon in Q3 2025, an estimated $11.4M increase.
  • Prelude Capital Management's biggest Q3 2025 reduction was Meta Platforms (Facebook), cutting an estimated $13.2M.
  • Prelude Capital Management fully exited Amedisys in Q3 2025, selling an estimated $8.89M.
  • Prelude Capital Management's ten largest holdings make up 13% of its $1.28B portfolio in Q3 2025.
  • Prelude Capital Management opened 471 new positions and closed 327 in Q3 2025.
  • Prelude Capital Management's portfolio value rose 25% quarter-over-quarter to $1.28B.

Based on Prelude Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.